AstraZeneca launches pilot program for Cordio Medical’s AI heart failure app

Cordio Medical’s HearO app analyzes the voice of heart failure patients to monitor their condition. [Photo courtesy of Cordio Medical]

AstraZeneca and the Bellvitge University Hospital plan to launch the first pilot program for the Cordio Medical HearO app.

The HearO smartphone app provides widespread access to medical-grade technology for patients with congestive heart failure (CHF). It enables the patient to monitor symptoms, manage treatment and improve quality of life.

Astrazeneca said the pilot program aims to assess the feasibility of using the app to monitor CHF patients. The monitoring takes place in both the hospital and at-home settings. It includes tracking HearO’s success rate of patient compliance and its ability to issue notices prior to heart failure events.

Get the full story at our sister site, Medical Design & Outsourcing.

Read more
  • 0

AstraZeneca launches pilot program for Cordio Medical’s AI heart failure app

Cordio Medical’s HearO app analyzes the voice of heart failure patients to monitor their condition. [Photo courtesy of Cordio Medical]

AstraZeneca and the Bellvitge University Hospital plan to launch the first pilot program for the Cordio Medical HearO app.

The HearO smartphone app provides widespread access to medical-grade technology for patients with congestive heart failure (CHF). It enables the patient to monitor symptoms, manage treatment and improve quality of life.

Astrazeneca said the pilot program aims to assess the feasibility of using the app to monitor CHF patients. The monitoring takes place in both the hospital and at-home settings. It includes tracking HearO’s success rate of patient compliance and its ability to issue notices prior to heart failure events.

The study takes place over a 6-9 month period. Previous and ongoing studies in Israel and the U.S. tested and vali…

Read more
  • 0

May 2023 edition: Endolumik’s big step for safety, ortho hot topics, SaMD development lessons



Endolumik’s illuminated device takes a big step for safety

The top orthopedic device news out of AAOS 2023

SaMD development lessons from Cordio’s voice AI heart failure app

Orthopedic device tech advances

High in the Wind River mountains of present-day Wyoming, the inhabitants of a remote alpine village — perhaps the oldest in North America — may have used fresh rawhide soaked in water as a splint to immobilize fractured bones thousands of years ago.

Before them, the ancient Egyptians used tree bark and linens, and native tribes of South Australia used thick clay.

They would all no doubt be amazed by the modern practice of orthopedics on display at this year’s American Academy of Orthopaedic Surgeons (AAOS) annual meeting — after they recovered from the shock of the scintillating sights of Las Vegas.

In this edition of Medical Design & Outsourcing, Executive E…

Read more
  • 0

May 2023 edition: Endolumik’s big step for safety, ortho hot topics, SaMD development lessons



Endolumik’s illuminated device takes a big step for safety

The top orthopedic device news out of AAOS 2023

SaMD development lessons from Cordio’s voice AI heart failure app

Orthopedic device tech advances

High in the Wind River mountains of present-day Wyoming, the inhabitants of a remote alpine village — perhaps the oldest in North America — may have used fresh rawhide soaked in water as a splint to immobilize fractured bones thousands of years ago.

Before them, the ancient Egyptians used tree bark and linens, and native tribes of South Australia used thick clay.

They would all no doubt be amazed by the modern practice of orthopedics on display at this year’s American Academy of Orthopaedic Surgeons (AAOS) annual meeting — after they recovered from the shock of the scintillating sights of Las Vegas.

In this edition of Medical Design & Outsourcing, Executive E…

Read more
  • 0

SaMD development lessons from Cordio’s voice AI heart failure app

Cardio Medical HearO app analyzes the voice of heart failure patients to monitor their condition. [Photo courtesy of Cordio Medical]

Software as a medical device (SaMD) development requires a different approach than traditional medical devices in a few ways.

Repeat after me: My dad is a big chef.

Speaking that short sentence and a few others like it into a smartphone once a day helps identify deteriorating heart failure patients at risk of declining, Cordio Medical CEO Tamir Tal said.

Israel-based Cordio developed its software as a medical device (SaMD) product, the artificial intelligence (AI) voice app HearO, after a cardiologist noticed he could hear congestion in a declining patient’s voice. HearO compares a patient’s voice against baseline recordings to detect lung fluid build-up and alert their care team.

“The holy grail of the entire [heart failure] monitoring industry…

Read more
  • 0